HistoRx offfers the first advanced histopathology analysis platform, using the company's proprietary AQUAr technology capable of measuring biomarker concentration with sub-cellular resolution in tissue sections. AQUAr analysis of biomarkers generates more precise, efficient, and cost-effective answers about the safety and effectiveness of new therapeutics in development and provides the foundation for companion diagnostic tests.
